Mythili Srinivasan1, Cassandra Pruitt2, Erin Casey3, Keerat Dhaliwal2, Cori DeSanto2, Richard Markus4, Ayelet Rosen2. 1. Department of Pediatrics, Washington University, St Louis, Missouri; srinivasanmythili@wustl.edu. 2. Department of Pediatrics, Washington University, St Louis, Missouri. 3. Department of Pediatrics, Stony Brook University, New York, New York; and. 4. Department of Pediatrics, University of Texas Southwestern Medical School, Dallas, Texas.
Abstract
BACKGROUND AND OBJECTIVES: Intravenous (IV) hydration is used primarily in children with bronchiolitis at our institution. Because nasogastric (NG) hydration can provide better nutrition, the goal of our quality improvement (QI) initiative was to increase the rate of NG hydration in eligible children 1 to 23 months old with bronchiolitis by 20% over 6 months. METHODS: We used Plan-Do-Study-Act cycles to increase the use of NG hydration in eligible children. Interventions included educational and system-based changes and sharing parental feedback with providers. Chart reviews were performed to identify the rates of NG hydration, which were plotted over time in a statistical process control p chart. The balancing measure was the rate of complications in children with NG versus IV hydration. RESULTS: Two hundred and ninety-three children who were hospitalized with bronchiolitis needed supplemental hydration during the QI initiative (January 2016-April 2016). Ninety-one children were candidates for NG hydration, and 53 (58%) received NG hydration. The rates of NG hydration increased from a baseline of 0% pre-QI bronchiolitis season (January 2015-April 2015) to 58% during the initiative. There was no aspiration and no accidental placement of the NG tube into a child's airway. Nine patients (17%) in the NG group had a progression of disease requiring nil per os status, and 6 of these were transferred to the PICU whereas none of those in the IV group were transferred to the PICU. Post-QI initiative, the majority of nurses (63%) and physicians (95%) stated that they are more likely to consider NG hydration in children with bronchiolitis. CONCLUSIONS: We successfully increased the rates of NG hydration in eligible children with bronchiolitis by using educational and system-based interventions.
BACKGROUND AND OBJECTIVES: Intravenous (IV) hydration is used primarily in children with bronchiolitis at our institution. Because nasogastric (NG) hydration can provide better nutrition, the goal of our quality improvement (QI) initiative was to increase the rate of NG hydration in eligible children 1 to 23 months old with bronchiolitis by 20% over 6 months. METHODS: We used Plan-Do-Study-Act cycles to increase the use of NG hydration in eligible children. Interventions included educational and system-based changes and sharing parental feedback with providers. Chart reviews were performed to identify the rates of NG hydration, which were plotted over time in a statistical process control p chart. The balancing measure was the rate of complications in children with NG versus IV hydration. RESULTS: Two hundred and ninety-three children who were hospitalized with bronchiolitis needed supplemental hydration during the QI initiative (January 2016-April 2016). Ninety-one children were candidates for NG hydration, and 53 (58%) received NG hydration. The rates of NG hydration increased from a baseline of 0% pre-QI bronchiolitis season (January 2015-April 2015) to 58% during the initiative. There was no aspiration and no accidental placement of the NG tube into a child's airway. Nine patients (17%) in the NG group had a progression of disease requiring nil per os status, and 6 of these were transferred to the PICU whereas none of those in the IV group were transferred to the PICU. Post-QI initiative, the majority of nurses (63%) and physicians (95%) stated that they are more likely to consider NG hydration in children with bronchiolitis. CONCLUSIONS: We successfully increased the rates of NG hydration in eligible children with bronchiolitis by using educational and system-based interventions.
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Todd A Florin; Terri Byczkowski; Richard M Ruddy; Joseph J Zorc; Matthew Test; Samir S Shah Journal: J Pediatr Date: 2015-03-04 Impact factor: 4.406
Authors: Ed Oakley; Sonny Bata; Sharmila Rengasamy; David Krieser; John Cheek; Kim Jachno; Franz E Babl Journal: J Pediatr Date: 2016-08-10 Impact factor: 4.406
Authors: Ed Oakley; Meredith Borland; Jocelyn Neutze; Jason Acworth; David Krieser; Stuart Dalziel; Andrew Davidson; Susan Donath; Kim Jachno; Mike South; Theane Theophilos; Franz E Babl Journal: Lancet Respir Med Date: 2012-12-21 Impact factor: 30.700
Authors: Alexander Komashie; James Ward; Tom Bashford; Terry Dickerson; Gulsum Kubra Kaya; Yuanyuan Liu; Isla Kuhn; Aslι Günay; Katharina Kohler; Nicholas Boddy; Eugenia O'Kelly; Joseph Masters; John Dean; Catherine Meads; P John Clarkson Journal: BMJ Open Date: 2021-01-19 Impact factor: 2.692